Updating our understanding of pulmonary disease associated with HIV infection

Arch Bronconeumol. 2012 Apr;48(4):126-32. doi: 10.1016/j.arbres.2011.12.001. Epub 2012 Jan 17.
[Article in English, Spanish]

Abstract

The introduction of highly active antiretroviral therapy (HAART) has resulted in a reduction of opportunistic infections associated with cellular and humoral immunosuppression. However, what is still unclear is the impact of HAART on the development of other diseases not associated with AIDS, such as lung cancer and COPD. The aim of this paper is to review the most innovative and relevant aspects of lung pathology in patients infected with HIV.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections / epidemiology
  • AIDS-Related Opportunistic Infections / prevention & control
  • Antiretroviral Therapy, Highly Active
  • Comorbidity
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology*
  • Humans
  • Hypertension, Pulmonary / drug therapy
  • Hypertension, Pulmonary / epidemiology
  • Influenza, Human / epidemiology
  • Lung Diseases / epidemiology*
  • Lung Neoplasms / epidemiology
  • Male
  • Pneumococcal Vaccines
  • Pneumocystis carinii
  • Pneumonia, Pneumocystis / diagnosis
  • Pneumonia, Pneumocystis / drug therapy
  • Pneumonia, Pneumocystis / epidemiology
  • Pulmonary Disease, Chronic Obstructive / epidemiology
  • Pulmonary Disease, Chronic Obstructive / etiology
  • Smoking / epidemiology
  • Spain
  • Substance Abuse, Intravenous / epidemiology
  • Tuberculosis, Pulmonary / diagnosis
  • Tuberculosis, Pulmonary / epidemiology

Substances

  • Pneumococcal Vaccines